SCHEMBL23745968

SCHEMBL23745968

Nc1ccccc1NC(=O)c1cnc(NC(=O)C(N)c2ccccc2)cn1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 18/20 0.61
HDAC1 Q13547 16/20 0.61
HDAC2 Q92769 13/20 0.61
HDAC8 Q9BY41 6/20 0.61
HDAC6 Q9UBN7 3/20 0.61
NCOR1 O75376 3/20 0.61
HDAC10 Q969S8 2/20 0.53
HDAC11 Q96DB2 2/20 0.53
HDAC4 P56524 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
MAPK1 P28482 1/20 0.45
NCOR2 Q9Y618 7/20 0.44
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23745938 0.89 HDAC3 (0.63) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745937 0.87 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745953 0.84 HDAC3 (0.76) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745956 0.83 HDAC3 (0.64) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745954 0.82 HDAC1 (0.68) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745969 0.81 HDAC3 (0.61) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745970 0.81 HDAC3 (0.61) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23745951 0.78 HDAC3 (0.73) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23746023 0.76 HDAC1 (1.00) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23746010 0.73 HDAC1 (0.77) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158869-A1 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES AND NERVE DAMAGE, AND METHODS FOR PREPARING COMPOUNDS CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2021-08-12 WO disclosed